Moderna swung to profit and raised its revenue growth forecast to 15% to 25%

What happened: Moderna swung to profit and raised its revenue growth forecast to 15% to 25%, citing higher international COVID vaccine sales. Key numbers: Third-quarter revenue rose 29% from a year earlier. The prior outlook was up to 10% growth. Why it matters: The raised forecast signals stronger expected revenue growth than the company previously guided, alongside the return to profit. Coverage: 3 outlets in 24h

Moderna swung to profit and raised its revenue growth forecast to 15% to 25%, citing higher international COVID vaccine sales.

The raised forecast signals stronger expected revenue growth than the company previously guided, alongside the return to profit.